Preparation method of chitosan-g-antibacterial peptide polymer

A technology of chitosan and antibacterial peptide is applied in the field of preparation of antibacterial biological materials, which can solve the problems of limited practical application, high cytotoxicity and high production cost, and achieves easy mass production, low bactericidal concentration and low bacteriostatic concentration. Effect

Active Publication Date: 2018-12-04
烟台浩忆生物科技有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although natural antimicrobial peptides have this advantage, their clinical application is limited due to the disadvantages of high production cost, poor stability, and high cytotoxicity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of chitosan-g-antibacterial peptide polymer
  • Preparation method of chitosan-g-antibacterial peptide polymer
  • Preparation method of chitosan-g-antibacterial peptide polymer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] 1) Synthesis of amino acid derivatives: two amino acid derivatives, lysine-N-carboxylic anhydride (Lys NCA) and valine-N-carboxylic anhydride (ValNCA), were synthesized from benzyloxycarbonyl lysine and valine and Triphosgene reaction to get. The preparation process of the two amino acid derivatives is similar, and only lysine-N-carboxylic acid anhydride (Lys NCA) is used as an example to illustrate the synthesis process. Under nitrogen protection, a certain amount of benzyloxycarbonyllysine was dissolved in an appropriate amount of anhydrous tetrahydrofuran, accompanied by magnetic stirring. The feed ratio of benzyloxycarbonyllysine to triphosgene is 3:1, and triphosgene is added dropwise into the reaction vessel using a syringe. The mixture was warmed up to 50°C and reacted for 3 hours. After the system was clarified, it was cooled to room temperature, and the precipitate was washed three times with a large amount of n-hexane, and the precipitated product was obtain...

Embodiment 2

[0022] Get the chitosan-g-antibacterial peptide polymer solid that embodiment 1 obtains, be configured into the neutral aqueous solution of different concentration gradient, be respectively 4096 μ g / mL, 2048 μ g / mL, 1024 μ g / mL, 512 μ g / mL, 256 μ g / mL, 128 μg / mL, 64 μg / mL, 32 μg / mL, 16 μg / mL, 8 μg / mL, 4 μg / mL, 2 μg / mL, 0 μg / mL. Under the shaking incubation condition at 37°C, Escherichia coli reached the logarithmic growth phase of the bacteria in the LB culture medium. Diluted in LB culture medium to a bacterial concentration of 10 4 -10 5 CFU mL -1 . Mix 100 μL E. coli culture solution with 400 μL LB culture solution and 500 μL chitosan-g-antimicrobial peptide polymer aqueous solution, and add to the centrifuge tube. After incubation at 37°C for 24 hours, the medium was clear and transparent, and the concentration without obvious bacterial growth was determined as the minimum inhibitory concentration (MIC). The experimental results showed that the MIC value was 512 μg / mL....

Embodiment 3

[0024] Chitosan was prepared in the same way as in Example 1 for chitosan-g-antibacterial peptide polymers, and was configured into neutral aqueous solutions with different concentration gradients, which were 8192 μg / mL, 4096 μg / mL, 2048 μg / mL, and 1024 μg respectively. / mL, 512μg / mL, 256μg / mL, 128μg / mL, 64μg / mL, 32μg / mL, 16μg / mL, 8μg / mL, 4μg / mL, 2μg / mL, 0μg / mL. Under the shaking incubation condition at 37°C, Escherichia coli reached the logarithmic growth phase of the bacteria in the LB culture medium. Diluted in LB culture medium to a bacterial concentration of 10 4 -10 5 CFU mL -1 . Mix 100 μL E. coli culture solution with 400 μL LB culture solution and 500 μL chitosan aqueous solution, and add to the centrifuge tube. After incubation at 37°C for 24 hours, the medium was clear and transparent, and the concentration without obvious bacterial growth was determined as the minimum inhibitory concentration (MIC). The results showed that the MIC value was 2048 μg / mL. Dilute ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of a novel chitosan-g-antibacterial peptide polymer. The preparation method comprises following steps: at first, synthesizing two amino acid derivatives: lysine-N-carboxylic acid anhydride and valine-N-carboxylic acid anhydride; taking chitosan as a main chain; and grafting a polypeptide chain, which is prepared from lysine-N-carboxylic acid anhydride and valine-N-carboxylic acid anhydride through ring opening polymerization, to the amino groups of chitosan to prepare the chitosan-g-antibacterial peptide polymer. In a neutral medium, the prepared chitosan-g-antibacterial peptide polymer has the advantages of low minimal inhibitory concentration and low minimal bactericidal concentration; at the same time, the synthesis method is simple, the synthesis raw material cost is low, large scale production is easily realized, and due to the antibacterial performance in a neutral medium, the polymer has a high potential application value in the antibacterial field.

Description

technical field [0001] The invention belongs to the technical field of preparation of antibacterial biological materials, and in particular relates to a preparation method of a novel chitosan-g-antibacterial peptide polymer. Background technique [0002] In recent years, the emergence of drug-resistant bacteria and even superbugs has forced human beings to urgently develop new antibacterial agents to face this severe challenge. Different from the mechanism of action of conventional antibiotics, natural antimicrobial peptides achieve their antibacterial effects by destroying bacterial cell membranes. Because it only kills bacteria through electrostatic interaction and hydrophilic-hydrophobic interaction, it is difficult for bacteria to develop drug resistance. Although natural antimicrobial peptides have this advantage, their clinical application is limited due to the disadvantages of high production cost, poor stability, and high cytotoxicity. [0003] Natural antimicrobia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C08B37/08A61K31/785A61K47/61A61P31/04
Inventor 毕衍泽李岩
Owner 烟台浩忆生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products